All times are set to Eastern Standard Time.

All Industry supported CME educational sessions will be available at no cost. Learners can access this material via the HMP Education Network. Learn more here

February 7-9, 2025 | Fontainebleau Miami Beach

Register Now

Friday February 07, 2025

  • 12:00 PM – 1:00 PM

    Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)

  • +
    1:00 PM – 3:00 PM

    Leukemia Landscape: Research and Clinical Advances (Part 1)

    • 1:00 PM – 1:20 PM
      Updates in the Diagnosis and Classification of Myeloid Malignancies
    • 1:20 PM – 1:40 PM
      Updates in Low/Intermediate Risk Myelodysplastic Syndromes
    • 1:40 PM – 2:00 PM
      Updates in High-Risk Myelodysplastic Syndromes
    • 2:00 PM – 2:20 PM
      Updates in Chronic Myeloid Leukemia
    • 2:20 PM – 2:40 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 2:40 PM – 3:00 PM
      Question & Answer Panel
  • 3:00 PM – 3:30 PM

    Exhibit Hall

  • +
    3:30 PM – 5:30 PM

    Leukemia Landscape: Research and Clinical Advances (Part 2)

    • 3:30 PM – 3:50 PM
      Updates in Myeloproliferative Neoplasms
    • 3:50 PM – 4:10 PM
      Updates in Acute Lymphoblastic Leukemia
    • 4:10 PM – 4:30 PM
      Updates in Front Line Acute Myeloid Leukemia
    • 4:30 PM – 4:50 PM
      Updates in Relapsed Acute Myeloid Leukemia
    • 4:50 PM – 5:10 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 5:10 PM – 5:30 PM
      Question & Answer Panel
  • 5:30 PM – 6:30 PM

    Innovation Theater/Symposium (Non-Accredited) (Sponsored by Amgen)

  • 6:30 PM – 7:30 PM

    Exhibit Hall Welcome Reception

Saturday February 08, 2025

  • 7:30 AM – 8:30 AM

    Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)

  • +
    8:30 AM – 10:30 AM

    CLL Landscape: Research and Clinical Advances

    • 8:30 AM – 8:50 AM
      Updates in New Classifications and Risk Stratifications
    • 8:50 AM – 9:10 AM
      Updates in Bispecific Antibodies, Degraders, CAR-T Cells
    • 9:10 AM – 9:30 AM
      Updates in BTKi + BCL2 Therapy in the Retreatment Population
    • 9:30 AM – 9:50 AM
      Updates in the Management of BTK Resistance & Mutations
    • 9:50 AM – 10:10 AM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 10:10 AM – 10:30 AM
      Question & Answer Panel
  • 10:30 AM – 11:00 AM

    Exhibit Hall

  • +
    11:00 AM – 1:00 PM

    Multiple Myeloma Landscape: Research and Clinical Advances (Part 1)

    • 11:00 AM – 11:20 AM
      Updates in basic science, pathophysiology, and diagnosis (including MRD & P53)
    • 11:20 AM – 11:40 AM
      Updates in Precursor Disorders
    • 11:40 AM – 12:00 PM
      Updates in Front Line – Transplant Eligible Multiple Myeloma
    • 12:00 PM – 12:20 PM
      Updates in Front Line – Transplant Ineligible Multiple Myeloma
    • 12:20 PM – 12:40 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 12:40 PM – 1:00 PM
      Question & Answer Panel
View Full Agenda